Uncategorized

NuVasive Ups Bet on Orthobiologics

Alex Lukianov, NuVasive Chair and CEO, is hoping to fill a gap in the $1 billion orthobiologics market between BMPs (bone morphogenic proteins) and commodity synthetic and allograft bone extenders.

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button